Inappropriate schedule of vaccine administered; Inappropriate schedule of vaccine administered; Product origin unknown; This spontaneous report was received from a Physician via medical records (MR) regarding a case in litigation and refers to a 9-month-old female patient. The patient’s medical history, concurrent conditions, concomitant therapies were not reported. On 11-JAN-2005, the patient was vaccinated with the first dose of hepatitis b vaccine (recombinant) (manufactured unknown) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). The vaccine could either be hepatitis b vaccine (recombinant) (RECOMBIVAX HB) or hepatitis b vaccine rhbsag (yeast) (ENGERIX B) (Product origin unknown). On 25-APR-2005, the patient received the second dose of hepatitis b vaccine (recombinant) (manufactured unknown) (Inappropriate schedule of product administration). On 26-AUG-2005, the patient received the third dose of hepatitis b vaccine (recombinant) (manufactured unknown) (Inappropriate schedule of product administration). This is one of the 3 cases referred to the same patient.; Sender’s Comments: US-009507513-2412USA007989: US-009507513-2501USA009383: